Biomerica Inc BMRA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:35 PM EDT
0.60quote price arrow up+0.027 (+4.7285%)
Volume
643
Close
0.571quote price arrow down-0.0172 (-2.9242%)
Volume
406,130
52 week range
0.50 - 2.13
Loading...
  • Open0.586
  • Day High0.6388
  • Day Low0.5488
  • Prev Close0.5882
  • 52 Week High2.13
  • 52 Week High Date12/18/23
  • 52 Week Low0.50
  • 52 Week Low Date04/29/24

Key Stats

  • Market Cap9.605M
  • Shares Out16.82M
  • 10 Day Average Volume1.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.98
  • YTD % Change-54.32

KEY STATS

  • Open0.586
  • Day High0.6388
  • Day Low0.5488
  • Prev Close0.5882
  • 52 Week High2.13
  • 52 Week High Date12/18/23
  • 52 Week Low0.50
  • 52 Week Low Date04/29/24
  • Market Cap9.605M
  • Shares Out16.82M
  • 10 Day Average Volume1.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.98
  • YTD % Change-54.32

RATIOS/PROFITABILITY

  • EPS (TTM)-0.38
  • P/E (TTM)-1.51
  • Fwd P/E (NTM)-2.38
  • EBITDA (TTM)-6.597M
  • ROE (TTM)-92.06%
  • Revenue (TTM)5.405M
  • Gross Margin (TTM)11.41%
  • Net Margin (TTM)-117.46%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/28/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Biomerica Inc

 

Profile

MORE
Biomerica, Inc. is a biomedical technology company. The Company develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians’ offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. It is also engaged in the research, development, commercialization and in certain cases regulatory approval, of patented, diagnostic-guided therapy (DGT)...
Jack Kenny
Chairman of the Board
Allen Barbieri
Lead Executive Vice Chairman of the Board, Corporate Secretary
Zackary Irani
Chief Executive Officer
Gary Lu
Chief Financial Officer
Address
17571 VON KARMAN AVENUE
Irvine, CA
92614
United States

Top Peers

SYMBOLLASTCHG%CHG
NXGL
Nexgel Inc
2.21+0.01+0.45%
SINT
SINTX Technologies Inc
0.0447+0.0027+6.4286%
NBY
NovaBay Pharmaceuticals Inc
0.0865-0.0045-4.9451%
LUCD
Lucid Diagnostics Inc
1.03-0.01-0.96%
MLSS
Milestone Scientific Inc
0.687-0.0128-1.8291%